Physostigmine (Eserine) is a reversible acetylcholinesterase (AChE) inhibitor. Physostigmine can crosses the blood-brain barrier and stimulates central cholinergic neurotransmission. Physostigmine can reverse memory deficits in transgenic mice with Alzheimer's disease. Physostigmine is also an antidote for anticholinergic poisoning.

(1S,2S)-1-(4-O-β-D-Glucopyranosyl-3,5-dimethoxyphenyl)-2-[3-(4-O-β-D-glucopyranosyl-3,5-dimethoxyphenyl)-2-propen-1-yl]-1,3-propanediol

BAY-3827 is a potent and selective AMPK inhibitor with potential antitumor activity, demonstrating antiproliferative effects in an androgen-dependent prostate cancer model and inhibiting the phosphorylation of acetyl CoA carboxylase 1 (ACC-1).